How rapidly does lurbinectedin cause hypersensitivity reactions?

How fast do hypersensitivity reactions develop after lurbinectedin?

Lurbinectedin is given as a one-hour infusion. Hypersensitivity reactions can occur during the infusion itself or within minutes after it ends. Most cases tied to this drug appear early in treatment, usually during the ersten cycles.

What happens if a reaction develops during treatment?

Patients receive lurbinectedin under constant medical supervision. Staff watch for signs such as flushing, rash, hives, breathing difficulty, or blood pressure drops. If any warning signs appear, the infusion stops right away. Supportive measures such as antihistamines, corticosteroids, or epinephrine are used to treat the reaction.

Why do some patients develop these reactions?

Lurbinectedin itself is not a large molecule, but the formulation contains excipients that can trigger immune responses. The drug is administered every three weeks. Scheduling multiple infusions over months allows cumulative exposure to increase the chance of developing sensitivity.

Can lurbinectedin be restarted after a reaction?

Restart attempts require careful consideration. Low-grade reactions may erlauben erneute dosierung at a reduced rate or with premedication. Severe reactions often lead to discontinuation. Data from clinical studies show that a portion of patients who experienced mild reactions could receive further doses, but safety data are limited.

When does the patent expire?

The primary U.S. patent covering lurbinectedin expires in 2033. The drug is marketed by Jazz Pharmaceuticals.